0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psilocybin Assisted Therapy Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-28H12771
Home | Market Reports | Health| Pharmacy
Global Psilocybin Assisted Therapy Market Research Report 2023
BUY CHAPTERS

Global Psilocybin Assisted Therapy Market Research Report 2025

Code: QYRE-Auto-28H12771
Report
July 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Psilocybin Assisted Therapy Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psilocybin Assisted Therapy Market

Psilocybin Assisted Therapy Market

The global market for Psilocybin Assisted Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Psilocybin Assisted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psilocybin Assisted Therapy.
The Psilocybin Assisted Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psilocybin Assisted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psilocybin Assisted Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Psilocybin Assisted Therapy Market Report

Report Metric Details
Report Name Psilocybin Assisted Therapy Market
CAGR 5%
Segment by Type
  • Natural
  • Synthetic
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MindMed, Compass Pathways, ATAI Life Sciences, Field Trip, DemeRx, Eleusis, Hikma Pharmaceuticals PLC, Pfizer, Verrian, Jazz Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Psilocybin Assisted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Psilocybin Assisted Therapy Market report?

Ans: The main players in the Psilocybin Assisted Therapy Market are MindMed, Compass Pathways, ATAI Life Sciences, Field Trip, DemeRx, Eleusis, Hikma Pharmaceuticals PLC, Pfizer, Verrian, Jazz Pharmaceuticals

What are the Application segmentation covered in the Psilocybin Assisted Therapy Market report?

Ans: The Applications covered in the Psilocybin Assisted Therapy Market report are Cluster Headaches, Anxiety Disorders, Psychiatric Disorders

What are the Type segmentation covered in the Psilocybin Assisted Therapy Market report?

Ans: The Types covered in the Psilocybin Assisted Therapy Market report are Natural, Synthetic

Recommended Reports

Mental Health Therapy

Physical Therapy Devices

Emerging Drug Therapies

1 Psilocybin Assisted Therapy Market Overview
1.1 Product Definition
1.2 Psilocybin Assisted Therapy by Type
1.2.1 Global Psilocybin Assisted Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Natural
1.2.3 Synthetic
1.3 Psilocybin Assisted Therapy by Application
1.3.1 Global Psilocybin Assisted Therapy Market Value by Application (2024 VS 2031)
1.3.2 Cluster Headaches
1.3.3 Anxiety Disorders
1.3.4 Psychiatric Disorders
1.4 Global Psilocybin Assisted Therapy Market Size Estimates and Forecasts
1.4.1 Global Psilocybin Assisted Therapy Revenue 2020-2031
1.4.2 Global Psilocybin Assisted Therapy Sales 2020-2031
1.4.3 Global Psilocybin Assisted Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Psilocybin Assisted Therapy Market Competition by Manufacturers
2.1 Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Psilocybin Assisted Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Psilocybin Assisted Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psilocybin Assisted Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psilocybin Assisted Therapy, Product Type & Application
2.7 Global Key Manufacturers of Psilocybin Assisted Therapy, Date of Enter into This Industry
2.8 Global Psilocybin Assisted Therapy Market Competitive Situation and Trends
2.8.1 Global Psilocybin Assisted Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Psilocybin Assisted Therapy Players Market Share by Revenue
2.8.3 Global Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Psilocybin Assisted Therapy Market Scenario by Region
3.1 Global Psilocybin Assisted Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Psilocybin Assisted Therapy Sales by Region: 2020-2031
3.2.1 Global Psilocybin Assisted Therapy Sales by Region: 2020-2025
3.2.2 Global Psilocybin Assisted Therapy Sales by Region: 2026-2031
3.3 Global Psilocybin Assisted Therapy Revenue by Region: 2020-2031
3.3.1 Global Psilocybin Assisted Therapy Revenue by Region: 2020-2025
3.3.2 Global Psilocybin Assisted Therapy Revenue by Region: 2026-2031
3.4 North America Psilocybin Assisted Therapy Market Facts & Figures by Country
3.4.1 North America Psilocybin Assisted Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Psilocybin Assisted Therapy Sales by Country (2020-2031)
3.4.3 North America Psilocybin Assisted Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Psilocybin Assisted Therapy Market Facts & Figures by Country
3.5.1 Europe Psilocybin Assisted Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Psilocybin Assisted Therapy Sales by Country (2020-2031)
3.5.3 Europe Psilocybin Assisted Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psilocybin Assisted Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Psilocybin Assisted Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Psilocybin Assisted Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific Psilocybin Assisted Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Psilocybin Assisted Therapy Market Facts & Figures by Country
3.7.1 Latin America Psilocybin Assisted Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Psilocybin Assisted Therapy Sales by Country (2020-2031)
3.7.3 Latin America Psilocybin Assisted Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Psilocybin Assisted Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Psilocybin Assisted Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Psilocybin Assisted Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psilocybin Assisted Therapy Sales by Type (2020-2031)
4.1.1 Global Psilocybin Assisted Therapy Sales by Type (2020-2025)
4.1.2 Global Psilocybin Assisted Therapy Sales by Type (2026-2031)
4.1.3 Global Psilocybin Assisted Therapy Sales Market Share by Type (2020-2031)
4.2 Global Psilocybin Assisted Therapy Revenue by Type (2020-2031)
4.2.1 Global Psilocybin Assisted Therapy Revenue by Type (2020-2025)
4.2.2 Global Psilocybin Assisted Therapy Revenue by Type (2026-2031)
4.2.3 Global Psilocybin Assisted Therapy Revenue Market Share by Type (2020-2031)
4.3 Global Psilocybin Assisted Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Psilocybin Assisted Therapy Sales by Application (2020-2031)
5.1.1 Global Psilocybin Assisted Therapy Sales by Application (2020-2025)
5.1.2 Global Psilocybin Assisted Therapy Sales by Application (2026-2031)
5.1.3 Global Psilocybin Assisted Therapy Sales Market Share by Application (2020-2031)
5.2 Global Psilocybin Assisted Therapy Revenue by Application (2020-2031)
5.2.1 Global Psilocybin Assisted Therapy Revenue by Application (2020-2025)
5.2.2 Global Psilocybin Assisted Therapy Revenue by Application (2026-2031)
5.2.3 Global Psilocybin Assisted Therapy Revenue Market Share by Application (2020-2031)
5.3 Global Psilocybin Assisted Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MindMed
6.1.1 MindMed Company Information
6.1.2 MindMed Description and Business Overview
6.1.3 MindMed Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MindMed Psilocybin Assisted Therapy Product Portfolio
6.1.5 MindMed Recent Developments/Updates
6.2 Compass Pathways
6.2.1 Compass Pathways Company Information
6.2.2 Compass Pathways Description and Business Overview
6.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Compass Pathways Psilocybin Assisted Therapy Product Portfolio
6.2.5 Compass Pathways Recent Developments/Updates
6.3 ATAI Life Sciences
6.3.1 ATAI Life Sciences Company Information
6.3.2 ATAI Life Sciences Description and Business Overview
6.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio
6.3.5 ATAI Life Sciences Recent Developments/Updates
6.4 Field Trip
6.4.1 Field Trip Company Information
6.4.2 Field Trip Description and Business Overview
6.4.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Field Trip Psilocybin Assisted Therapy Product Portfolio
6.4.5 Field Trip Recent Developments/Updates
6.5 DemeRx
6.5.1 DemeRx Company Information
6.5.2 DemeRx Description and Business Overview
6.5.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DemeRx Psilocybin Assisted Therapy Product Portfolio
6.5.5 DemeRx Recent Developments/Updates
6.6 Eleusis
6.6.1 Eleusis Company Information
6.6.2 Eleusis Description and Business Overview
6.6.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eleusis Psilocybin Assisted Therapy Product Portfolio
6.6.5 Eleusis Recent Developments/Updates
6.7 Hikma Pharmaceuticals PLC
6.7.1 Hikma Pharmaceuticals PLC Company Information
6.7.2 Hikma Pharmaceuticals PLC Description and Business Overview
6.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio
6.7.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Psilocybin Assisted Therapy Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Verrian
6.9.1 Verrian Company Information
6.9.2 Verrian Description and Business Overview
6.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Verrian Psilocybin Assisted Therapy Product Portfolio
6.9.5 Verrian Recent Developments/Updates
6.10 Jazz Pharmaceuticals
6.10.1 Jazz Pharmaceuticals Company Information
6.10.2 Jazz Pharmaceuticals Description and Business Overview
6.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio
6.10.5 Jazz Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psilocybin Assisted Therapy Industry Chain Analysis
7.2 Psilocybin Assisted Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psilocybin Assisted Therapy Production Mode & Process Analysis
7.4 Psilocybin Assisted Therapy Sales and Marketing
7.4.1 Psilocybin Assisted Therapy Sales Channels
7.4.2 Psilocybin Assisted Therapy Distributors
7.5 Psilocybin Assisted Therapy Customer Analysis
8 Psilocybin Assisted Therapy Market Dynamics
8.1 Psilocybin Assisted Therapy Industry Trends
8.2 Psilocybin Assisted Therapy Market Drivers
8.3 Psilocybin Assisted Therapy Market Challenges
8.4 Psilocybin Assisted Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Psilocybin Assisted Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Psilocybin Assisted Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Psilocybin Assisted Therapy Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Psilocybin Assisted Therapy Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Psilocybin Assisted Therapy Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Psilocybin Assisted Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Psilocybin Assisted Therapy, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Psilocybin Assisted Therapy, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Psilocybin Assisted Therapy, Product Type & Application
 Table 12. Global Key Manufacturers of Psilocybin Assisted Therapy, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Psilocybin Assisted Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psilocybin Assisted Therapy as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Psilocybin Assisted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Psilocybin Assisted Therapy Sales by Region (2020-2025) & (K Units)
 Table 18. Global Psilocybin Assisted Therapy Sales Market Share by Region (2020-2025)
 Table 19. Global Psilocybin Assisted Therapy Sales by Region (2026-2031) & (K Units)
 Table 20. Global Psilocybin Assisted Therapy Sales Market Share by Region (2026-2031)
 Table 21. Global Psilocybin Assisted Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2020-2025)
 Table 23. Global Psilocybin Assisted Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2026-2031)
 Table 25. North America Psilocybin Assisted Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Psilocybin Assisted Therapy Sales by Country (2020-2025) & (K Units)
 Table 27. North America Psilocybin Assisted Therapy Sales by Country (2026-2031) & (K Units)
 Table 28. North America Psilocybin Assisted Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Psilocybin Assisted Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Psilocybin Assisted Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Psilocybin Assisted Therapy Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Psilocybin Assisted Therapy Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Psilocybin Assisted Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Psilocybin Assisted Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Psilocybin Assisted Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Psilocybin Assisted Therapy Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Psilocybin Assisted Therapy Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Psilocybin Assisted Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Psilocybin Assisted Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Psilocybin Assisted Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Psilocybin Assisted Therapy Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Psilocybin Assisted Therapy Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Psilocybin Assisted Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Psilocybin Assisted Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Psilocybin Assisted Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Psilocybin Assisted Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Psilocybin Assisted Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Psilocybin Assisted Therapy Sales (K Units) by Type (2020-2025)
 Table 51. Global Psilocybin Assisted Therapy Sales (K Units) by Type (2026-2031)
 Table 52. Global Psilocybin Assisted Therapy Sales Market Share by Type (2020-2025)
 Table 53. Global Psilocybin Assisted Therapy Sales Market Share by Type (2026-2031)
 Table 54. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2020-2025)
 Table 57. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2026-2031)
 Table 58. Global Psilocybin Assisted Therapy Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Psilocybin Assisted Therapy Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Psilocybin Assisted Therapy Sales (K Units) by Application (2020-2025)
 Table 61. Global Psilocybin Assisted Therapy Sales (K Units) by Application (2026-2031)
 Table 62. Global Psilocybin Assisted Therapy Sales Market Share by Application (2020-2025)
 Table 63. Global Psilocybin Assisted Therapy Sales Market Share by Application (2026-2031)
 Table 64. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2020-2025)
 Table 67. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2026-2031)
 Table 68. Global Psilocybin Assisted Therapy Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Psilocybin Assisted Therapy Price (USD/Unit) by Application (2026-2031)
 Table 70. MindMed Company Information
 Table 71. MindMed Description and Business Overview
 Table 72. MindMed Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. MindMed Psilocybin Assisted Therapy Product
 Table 74. MindMed Recent Developments/Updates
 Table 75. Compass Pathways Company Information
 Table 76. Compass Pathways Description and Business Overview
 Table 77. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Compass Pathways Psilocybin Assisted Therapy Product
 Table 79. Compass Pathways Recent Developments/Updates
 Table 80. ATAI Life Sciences Company Information
 Table 81. ATAI Life Sciences Description and Business Overview
 Table 82. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. ATAI Life Sciences Psilocybin Assisted Therapy Product
 Table 84. ATAI Life Sciences Recent Developments/Updates
 Table 85. Field Trip Company Information
 Table 86. Field Trip Description and Business Overview
 Table 87. Field Trip Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Field Trip Psilocybin Assisted Therapy Product
 Table 89. Field Trip Recent Developments/Updates
 Table 90. DemeRx Company Information
 Table 91. DemeRx Description and Business Overview
 Table 92. DemeRx Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. DemeRx Psilocybin Assisted Therapy Product
 Table 94. DemeRx Recent Developments/Updates
 Table 95. Eleusis Company Information
 Table 96. Eleusis Description and Business Overview
 Table 97. Eleusis Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Eleusis Psilocybin Assisted Therapy Product
 Table 99. Eleusis Recent Developments/Updates
 Table 100. Hikma Pharmaceuticals PLC Company Information
 Table 101. Hikma Pharmaceuticals PLC Description and Business Overview
 Table 102. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product
 Table 104. Hikma Pharmaceuticals PLC Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Pfizer Psilocybin Assisted Therapy Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Verrian Company Information
 Table 111. Verrian Description and Business Overview
 Table 112. Verrian Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Verrian Psilocybin Assisted Therapy Product
 Table 114. Verrian Recent Developments/Updates
 Table 115. Jazz Pharmaceuticals Company Information
 Table 116. Jazz Pharmaceuticals Description and Business Overview
 Table 117. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product
 Table 119. Jazz Pharmaceuticals Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Psilocybin Assisted Therapy Distributors List
 Table 123. Psilocybin Assisted Therapy Customers List
 Table 124. Psilocybin Assisted Therapy Market Trends
 Table 125. Psilocybin Assisted Therapy Market Drivers
 Table 126. Psilocybin Assisted Therapy Market Challenges
 Table 127. Psilocybin Assisted Therapy Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Psilocybin Assisted Therapy
 Figure 2. Global Psilocybin Assisted Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Psilocybin Assisted Therapy Market Share by Type: 2024 & 2031
 Figure 4. Natural Product Picture
 Figure 5. Synthetic Product Picture
 Figure 6. Global Psilocybin Assisted Therapy Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Psilocybin Assisted Therapy Market Share by Application: 2024 & 2031
 Figure 8. Cluster Headaches
 Figure 9. Anxiety Disorders
 Figure 10. Psychiatric Disorders
 Figure 11. Global Psilocybin Assisted Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Psilocybin Assisted Therapy Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Psilocybin Assisted Therapy Sales (2020-2031) & (K Units)
 Figure 14. Global Psilocybin Assisted Therapy Average Price (USD/Unit) & (2020-2031)
 Figure 15. Psilocybin Assisted Therapy Report Years Considered
 Figure 16. Psilocybin Assisted Therapy Sales Share by Manufacturers in 2024
 Figure 17. Global Psilocybin Assisted Therapy Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Psilocybin Assisted Therapy Players: Market Share by Revenue in Psilocybin Assisted Therapy in 2024
 Figure 19. Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Psilocybin Assisted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Psilocybin Assisted Therapy Sales Market Share by Country (2020-2031)
 Figure 22. North America Psilocybin Assisted Therapy Revenue Market Share by Country (2020-2031)
 Figure 23. United States Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Psilocybin Assisted Therapy Sales Market Share by Country (2020-2031)
 Figure 26. Europe Psilocybin Assisted Therapy Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Psilocybin Assisted Therapy Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Psilocybin Assisted Therapy Revenue Market Share by Region (2020-2031)
 Figure 34. China Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Psilocybin Assisted Therapy Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Psilocybin Assisted Therapy Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Psilocybin Assisted Therapy Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Psilocybin Assisted Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Psilocybin Assisted Therapy by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Psilocybin Assisted Therapy by Type (2020-2031)
 Figure 55. Global Psilocybin Assisted Therapy Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Psilocybin Assisted Therapy by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Psilocybin Assisted Therapy by Application (2020-2031)
 Figure 58. Global Psilocybin Assisted Therapy Price (USD/Unit) by Application (2020-2031)
 Figure 59. Psilocybin Assisted Therapy Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS